R01AR082536 (ELEFTERIOU, FLORENT)Apr 1, 2024 - Mar 31, 2029 NIH TonEBP/Nfat5, vesicular trafficking and intervertebral disc maintenance Role: Principal Investigator |
|
R21AR083029 (ELEFTERIOU, FLORENT)Apr 1, 2024 - Mar 31, 2026 NIH Characterizing the cell-of-origin for NF1 dystrophic scoliosis Role: Principal Investigator |
|
R01AR077949 (ELEFTERIOU, FLORENT)Apr 1, 2021 - Mar 31, 2026 NIH Etiology of musculoskeletal maladies in NF1 Role: Principal Investigator |
|
R21AR072483 (NYMAN, JEFFRY STEPHEN)Mar 1, 2018 - Feb 28, 2021 NIH Matrix-Sensitive Tools for Detecting NF1-Related Changes in Bone Quality Role: Co-Principal Investigator |
|
R01AG055394 (ELEFTERIOU, FLORENT)Jul 15, 2017 - May 31, 2022 NIH Senile Osteoporosis as a Neuroskeletal Disease Role: Principal Investigator |
|
R01CA168717 (ELEFTERIOU, FLORENT)Apr 1, 2013 - Mar 31, 2019 NIH Role of Sympathetic Activation and RANKL/IL6 in Breast Cancer Bone Metastasis Role: Principal Investigator |
|
R01DK082471 (ELEFTERIOU, FLORENT)Jul 18, 2009 - May 31, 2015 NIH The Norepinephrine Transporter as a Novel Target for a Bone Anabolic Treatment Role: Principal Investigator |
|
R01AR055966 (ELEFTERIOU, FLORENT)Jul 1, 2009 - Jun 30, 2015 NIH Bone Pseudoarthrosis Dissected through the Generation of New Mouse Models Role: Principal Investigator |
|
R56AR055966 (ELEFTERIOU, FLORENT)Mar 31, 2008 - Aug 31, 2017 NIH Bone pseudarthrosis: from mouse models to pharmacological therapies Role: Principal Investigator |
|
R21AR053978 (ELEFTERIOU, FLORENT)Sep 1, 2006 - Aug 31, 2009 NIH NEUROFIBROMIN (Nf1) SIGNALING AND TARGET GENES IN OSTEOBLASTS Role: Principal Investigator |
|
R21DK074994 (ELEFTERIOU, FLORENT)Apr 1, 2006 - Mar 31, 2009 NIH Glucocorticoid-induced bone loss via Beta2-adrenergic signaling in osteoblasts Role: Principal Investigator |
|
P01CA040035 (ELEFTERIOU, FLORENT)Sep 30, 1985 - Aug 31, 2013 NIH Effect of Tumors on the Skeleton Role: Principal Investigator |